FdaApplication
NDA 205352
Identifiers
- fda_app_no: NDA205352
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE CONSUMER CARE |
| application_type | NDA |
| approval_date | 2014-01-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ALEVE PM | DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM | 25MG;220MG | TABLET;ORAL |
1 product